Achievement
year
Authors
Language
Paper Title
2024
Chen WT, Chung FP*, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chao TF, Liao JN, Lin CY, Chang TY, Kuo L, Wu C, Liu CM, Liu SH, Hsieh YC, Li CH, Chen SA.
J. Cardiovasc. Electrophysiol. 2024; 35(1): 60-68. (IF: 2.300)
Lower contact force predicts right pulmonary vein carina breakthrough after ablation index-guided pulmonary vein isolation using high-power short-duration.
2024
Chen WW, Liu CM, Tseng CC, Huang CC, Wu IC, Chen PF, Chang SL, Lin YJ, Lo LW, Chung FP, Chao TF, Tuan TC, Liao JN, Lin CY, Chang TY, Kuo L, Wu C, Liu SH, Wu JCH, Hu YF*, Chen SA*, Lu HHS*.
BMC Med. Res. Methodol. 2024; 24(1):318. (IF:3.900)
Identifying the presence of atrial fibrillation during sinus rhythm using a dual-input mixed neural network with ECG coloring technology.
2024
Chen Y, Gue Y, Calvert P, Gupta D, McDowell G, Azariah JL, Namboodiri N, Bucci T, Jabir A, Tse HF, Chao TF, Lip GYH*, Bahuleyan CG*.
Curr. Probl. Cardiol. 2024; 49(4):102456. (IF:3.000)
Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry.
2024
Chen YY, Chang HC, Lin YJ*, Chien KL, Hsieh YC, Chung FP, Lin CH, Lip GYH, Chen SA.
Diabetes-Metab. Res. Rev. 2024; 40(2):e3775. (IF:4.600)
The impact of sodium-glucose co-transporter-2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation.
2024
Chen ZW, Liao CW, Pan CT, Tsai CH, Chang YY, Chang CC, Lee BC, Chiu YW, Huang WC, Lai TS, Lu CC, Chueh JS, Wu VC, Hung CS, Lin YH*.
J. Hypertens. 2024; 42(3): 538-545. (IF: 3.300)
Reversal of arterial stiffness in medically and surgically treated unilateral primary aldosteronism.
2024
Cheng PN, Chen WJ, Hou CJY, Lin CL, Chang ML, Wang CC, Chang WT, Wang CY, Lin CY, Hung CL, Peng CY, Yu ML, Chao TH, Huang JF, Huang YH, Chen CY, Chiang CE, Lin HC, Li YH, Lin TH, Kao JH, Wang TD, Liu PY, Wu YW*, Liu CJ*.
Clin. Mol. Hepatol. 2024; 30(1): 16-36. (IF:14.000)
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases.
2024
Cheng WH, Lo LW, Chou YH, Liu SH, Lin WL, Chen SA.
Acta Cardiol. Sin. 2024; 40(6):729-739. (IF: 1.800)
Empagliflozin Ameliorates Atrial and Ventricular Remodeling and Arrhythmogenesis in an Overweight Rabbit Model.
2024
Chin CG, Chen YC, Lin FJ, Lin YK, Lu YY, Cheng TY, Chen SA, Chen YJ*.
J. Biomed. Sci. 2024; 31(1):42. (IF:9.000)
Targeting NLRP3 signaling reduces myocarditis-induced arrhythmogenesis and cardiac remodeling.
2024
Chou RH, Yang SF, Huang PH*.
Acta Cardiol. Sin. 2024; 40(2): 260-261. (IF: 1.800)
Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients.
2024
Chuang MJ, Huang WC*, Chen YY, Lu TM.
J. Interv. Cardiol. 2024; (IF: 1.600)
The Short-Term and One-Year Clinical Outcomes in Patients with Optical Coherence Tomography-Guided Magmaris Implantation: A Real-World Clinical Practice.